Clinical Trials Logo

Filter by:
NCT ID: NCT06283355 Not yet recruiting - Clinical trials for Microbial Colonization

Comparing Single Versus Repeat NMT on the Diversity of the Neonatal Nasal Microbiome

Start date: August 1, 2024
Phase: Phase 1
Study type: Interventional

This study aims to determine whether a parent-to-child nasal microbiota transplant (NMT) can seed and engraft parental organisms into the neonatal microbiome and increase the neonatal microbiome diversity.

NCT ID: NCT06283251 Not yet recruiting - Pediatric Cancer Clinical Trials

PediRISE Feasibility

Start date: June 2024
Phase: N/A
Study type: Interventional

The goal of this research study is to learn whether investigators can successfully give the PediRISE program to families-in other words, whether most families are interested in participating in a study about the PediRISE program, including a 50-50 chance of receiving standard usual care, and a 50-50 chance of receiving the PediRISE support program. The names of the study groups in this research study are: - PediRISE Program Group - Usual Care Group

NCT ID: NCT06283238 Not yet recruiting - Clinical trials for GastroEsophageal Cancer

Biobanking Upper Gastrointestinal Tumors to Evaluate Response (BURGER With BACON)

Start date: June 17, 2024
Phase:
Study type: Observational

The goal of this observational study is to examine genetic changes that may contribute to immunotherapy resistance in gastroesophageal cancer. This information can potentially lead to the identification of new immunotherapeutic targets as well as improve the ability to identify those patients more likely to respond to immunotherapy. This study does not include any treatment or investigational drugs. Participants will be asked: - to enroll before beginning standard care of treatment for their cancer - for blood, archived tumor tissue, and fresh tumor tissue Researchers will compare participants who are not getting immunotherapy to identify potential differences in expression levels of a gene.

NCT ID: NCT06283173 Completed - Skin Sensitisation Clinical Trials

HRIPT for Collagen Dressing

Start date: January 31, 2024
Phase: N/A
Study type: Interventional

The objectives of this study are to determine by repetitive epidermal contact, the primary or cumulative irritation and the allergic contact sensitization potential of the ColActive Plus Collagen Matrix Dressing, under maximized conditions, with controlled product quantity and application site.

NCT ID: NCT06283108 Recruiting - Clinical trials for Dental Caries in Children

Gurney Journey: Virtual Reality Distraction

Start date: March 1, 2024
Phase: N/A
Study type: Interventional

The aim of this study is to determine whether a software virtual reality (VR) program provided during transportation to anesthesia induction reduces anxiety before the procedure, and compliance in pediatric patients. This study aims to measure the anxiety of patients as they arrive before their procedure, when parting from their parents for transportation to the procedure room, and when anesthesia is provided. Compliance during anesthesia induction will also be monitored. Participants will be randomly placed into to one of two groups. Group 1 will receive standard care from a Certified Child Life Specialist prior to their surgery. Group 2 will receive standard care from a Certified Child Life Specialist and distraction with a novel virtual reality software program.

NCT ID: NCT06283056 Recruiting - Cellulitis of Leg Clinical Trials

RF Microneedling With Multi-Depth Targeting Per Insertion for The Treatment of Cellulite

Start date: June 16, 2022
Phase: N/A
Study type: Interventional

The aim of the study is to evaluate the safety and efficacy of Morpheus 8 Body 40-pin tip up to 7mm depth Applicator for subdermal treatment of cellulite appearance, skin laxity, and subcutaneous fat deposits.

NCT ID: NCT06283030 Completed - Sleep Apnea Clinical Trials

Evaluation of Hypoglossal Nerve Stimulation in Humans With Obstructive Sleep Apnea

Start date: December 1, 2021
Phase: N/A
Study type: Interventional

This proof-of-concept study is being performed to evaluate whether the hypoglossal nerve can be stimulated using a small series of electrodes placed surgically via a percutaneous approach. Minimally invasive off the shelf medical devices will be used and observation of the characteristic physiological responses to stimulation of the HGN, will be assessed.

NCT ID: NCT06282939 Recruiting - Clinical trials for Intracranial Aneurysm

Optima Coil Performance in The Interventional Management of Intracranial Aneurysms Registry

OPTIMA
Start date: November 1, 2023
Phase:
Study type: Observational [Patient Registry]

This is a prospective, open-label, consecutive enrollment, multi-center, U.S. registry of patients with intracranial aneurysms who are treated with the Optima Coil System. The primary objective of this registry is to evaluate the safety and effectiveness of the OptimaTM Coil System, including the OptiMAX Coils, in the real-world treatment of intracranial aneurysms. Imaging will be analyzed by a designated core neuroimaging lab to assess procedural success and aneurysm occlusion rates. Intent to treat population total: 700 patients 600 patients, up to 100 screen failures.

NCT ID: NCT06282770 Recruiting - Spinal Fusion Clinical Trials

Photobiomodulation for Lower Back Pain Post Spinal Fusion and Decompression Surgery

Start date: July 1, 2023
Phase: N/A
Study type: Interventional

After spinal fusion and decompression surgery there is a possible risk of developing chronic back pain. After surgery there is typically inflammation around the operation site and this inflammation can be painful and debilitating to patients. Many possible treatment plans have been incorporated to assist the patient with recovery - notably medications, physical therapy, and braces. However, few studies have looked at laser diodes that utilize high-power laser lights that are aimed at decreasing pain and inflammation. Investigators aim to look compare patients using a back brace with laser diodes within versus those who wear a normal brace used as a placebo. Investigators will also assess the patient's surgical wound to monitor the progression of wound healing while using the brace.

NCT ID: NCT06282575 Recruiting - Clinical trials for Biliary Tract Cancer

Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer

Start date: June 30, 2024
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of Zanidatamab plus CisGem (Cisplatin and Gemcitabine) with or without the addition of a programmed death protein 1/ligand-1 (PD-1/L1) inhibitor (physician's choice of either Durvalumab or Pembrolizumab, where approved under local regulations) as first line of treatment for participants with human epidermal growth factor receptor 2 (HER2)-positive biliary tract cancer.